SS Innovations International, Inc. SSII
SS Innovations International, Inc. (Nasdaq: SSII) is a medical device company. Its next catalyst on record is SSi Mantra: US FDA 510(k) clearance decision (submitted 2025-12-05) (2026).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: SSi Mantra — US FDA 510(k) clearance decision (submitted 2025-12-05) (2026). 2 catalysts on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| SSi Mantra 3 surgical robotic system (CDSCO-approved India; US 510(k) submitted 2025-12-05; EU CE file with Szutest) | Robotic surgery | — | NA_NON_THERAPEUTIC |
| SSi Mudra surgical instruments | Robotic surgical instrumentation | — | NA_NON_THERAPEUTIC |
Recent results and decisions
- Oct 9, 2026n/a SS Innovations International closed a $20 million registered secured convertible promissory note financing with Growth Capital Partners, with the note carrying an 8.75% annual interest rate and a 36-month maturity.
Investor shall pay $20,000,000.00 (the 'Purchase Price') to Company via wire transfer of immediately available funds against delivery of the Note.
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.